Table 1.
Detrusor underactivity | ||
---|---|---|
| ||
No (n=156) | Yes (n=108) | |
Age at RP, year | 61 (56, 66) | 61 (57, 66) |
| ||
Pre-RP PSA, ng/mL | 6.6 (4.4, 9.2) | 5.7 (4, 8.9) |
| ||
Type of surgery | ||
Open | 119 (76%) | 66 (61%) |
Laparoscopic or robotic | 37 (24%) | 42 (39%) |
| ||
Year of RP | ||
before 1990 | 3 (2%) | 1 (1%) |
1990–1995 | 18 (12%) | 8 (7%) |
1995–2000 | 18 (12%) | 16 (15%) |
2000–2005 | 54 (35%) | 30 (28%) |
2005–2008 | 57 (37%) | 53 (49%) |
Missing | 6 (4%) | 0 (0%) |
| ||
Clinical stage | ||
≤T2A | 88 (56%) | 66 (61%) |
≥T2B | 23 (15%) | 25 (23%) |
Missing | 45 (29%) | 17 (16%) |
| ||
Nerve sparing status | ||
None | 21 (13%) | 18 (17%) |
Unilaterally | 12 (8%) | 9 (8%) |
Bilaterally | 72 (46%) | 53 (49%) |
Missing | 51 (33%) | 28 (26%) |
Biopsy Gleason grade | ||
≤6 | 63 (40%) | 47 (44%) |
=7 | 44 (28%) | 35 (32%) |
≥8 | 18 (12%) | 8 (7%) |
Missing | 31 (20%) | 18 (17%) |
| ||
Time between RP to UDS evaluation (months) to clinic visit, months | 38 (16, 89) | 25 (15, 75) |
| ||
Pelvic radiation | 34 (22%) | 19 (18%) |
Data are given as frequency (percentage) or median (interquartile range).
RP: radical prostatectomy; PSA: prostate-specific antigen; UDS: urodynamic studies.